Why the study?
In COPD, the diaphragm may contribute to respiratory decompensation, prompting investigation into whether adding transcranial magnetic stimulation to conventional rehabilitation could improve functional outcomes.
Does cortical or subcortical transcranial magnetic stimulation improve diaphragmatic function and exercise capacity in patients with COPD undergoing pulmonary rehabilitation?
Does cortical or subcortical transcranial magnetic stimulation improve diaphragmatic function and exercise capacity in patients with COPD undergoing pulmonary rehabilitation?
Answers are grounded in this paper and cite their sources.
The addition of cortical or subcortical transcranial magnetic stimulation to conventional pulmonary rehabilitation significantly improves diaphragmatic function and exercise capacity in patients with COPD.
Background Transcranial magnetic stimulation (TMS), a non-invasive method of electrically stimulating neurons in the cerebral cortex, can change neuronal and cortical activity locally and remotely by applying localized magnetic fields. TMS can be used to treat a variety of disorders and improve functional impairments by stimulating the motor cortex. Chronic obstructive pulmonary disease (COPD) is an invalidating disease that primarily compromises both respiratory and motor functions either during the acute or the chronic phase. In COPD, the diaphragm may contribute to respiratory decompensation This study aims to use TMS as a therapeutic tool in addition to conventional rehabilitative programs in COPD patients and assess this application using diaphragmatic ultrasonography (US) and 6-min walking test (6MWT). Result A case–control study with 60 COPD patients divided into three equal groups. The control group (group A) received the conventional rehabilitation program, group B received additional subcortical magnetic stimulation of the phrenic nerve roots in the neck, and group C received TMS of the diaphragmatic motor cortex area in addition. Before treatment, there was no significant difference between the groups in diaphragmatic US assessment (diaphragmatic thickness (DT) and diaphragmatic mobility (DM) or 6MWT ( P > 0.05). After treatment, there was a significant improvement in groups A and B, while a highly significant improvement in group C. Conclusion The application of cortical or subcortical TMS to COPD patients improves diaphragmatic function and daily activities significantly. These advancements allowed TMS to be considered as a therapeutic tool in the COPD rehabilitation program.
No takes yet. Share an insight, caveat, or question.
Elshoura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: